Current Perspectives on Biological Therapy for COPD
Chronic obstructive pulmonary disease (COPD) is a chronic, complex, and heterogeneous condition with significant mortality, morbidity, and socioeconomic burden. Given the heterogeneity, the current management of COPD, which mainly relies on bronchodilators and corticosteroids, cannot consider all CO...
Main Authors: | Ambedkar Kumar Yadav, Wenhua Gu, Tongyangzi Zhang, Xianghuai Xu, Li Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | COPD |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/15412555.2023.2187210 |
Similar Items
-
Triple Therapy for COPD: Historical Perspective and Current Controversies
by: Jose L. López-Campos
Published: (2023-01-01) -
Novel Anti-Inflammatory Approaches to COPD
by: Cazzola M, et al.
Published: (2023-06-01) -
Biological Anti-IL-5/IL-5R Therapeutics for Chronic Obstructive Pulmonary Disease (COPD) with Specific Treatable Traits: A Real-World Retrospective Analysis
by: Day de Larrañaga F, et al.
Published: (2024-01-01) -
Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
by: Calverley PMA, et al.
Published: (2019-12-01) -
Micro and macro analysis on the burden of COPD hospitalizations on the Bulgarian healthcare system
by: Konstantin Tachkov, et al.
Published: (2019-01-01)